Document is current
Any future updates will be listed below
-
Authors
Höchsmann, Christoph http://orcid.org/0000-0003-2007-3007
Dorling, James L. http://orcid.org/0000-0002-1917-2828
Martin, Corby K. http://orcid.org/0000-0002-8125-4015
Earnest, Conrad P. http://orcid.org/0000-0002-6546-1268
Church, Timothy S. http://orcid.org/0000-0002-1039-0298
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (T32DK064584, P30DK072476)
American Heart Association (20POST35210907)
National Institute of General Medical Sciences (U54 GM104940)
Technische Universität München
- License Information
-
More Information
Article History
Received: 7 January 2021
Accepted: 22 February 2022
First Online: 7 March 2022
Declarations
:
: Participation in the program was voluntary, and data were fully de-identified and did not contain employee names, or the city/state of their residence. The study was reviewed by an ethics committee (Chesapeake IRB, Columbia, MD). Because the research presented in the manuscript is secondary data analysis of de-identified data, the requirement to document informed consent was waived and the study was determined to be exempt from IRB oversight according to the tenets of the US Department of Health and Human Services regulations at 45 CFR 46.
: Not applicable.
: C.K.M. is a paid consultant and T.S.C serves as the Chief Medical Officer at Wondr Health™, Dallas, TX, USA. All other authors declare no conflicts of interest.
